Tower Research Capital LLC (Trc) Mirum Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,418 shares of MIRM stock, worth $71,197. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,418

Previous 7,197 80.3%

Holding current value

$71,197

Previous $246,000 77.64%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$33.68 - $44.74 $194,636 - $258,552	-5,779 Reduced 80.3%	1,418 $55,000
Q2 2024 Aug 13, 2024	BUY	$23.57 - $34.85 $90,603 - $133,963	3,844 Added 114.64%	7,197 $246,000
Q1 2024 May 15, 2024	SELL	$24.92 - $30.02 $21,979 - $26,477	-882 Reduced 20.83%	3,353 $84,000
Q4 2023 Feb 13, 2024	BUY	$27.14 - $34.93 $71,703 - $92,285	2,642 Added 165.85%	4,235 $125,000
Q3 2023 Nov 14, 2023	SELL	$24.63 - $32.85 $6,231 - $8,311	-253 Reduced 13.71%	1,593 $50,000
Q2 2023 Aug 14, 2023	BUY	$23.51 - $30.09 $28,259 - $36,168	1,202 Added 186.65%	1,846 $47,000
Q1 2023 May 09, 2023	SELL	$19.19 - $24.1 $32,335 - $40,608	-1,685 Reduced 72.35%	644 $15,000
Q4 2022 Feb 10, 2023	BUY	$17.59 - $23.83 $2,093 - $2,835	119 Added 5.38%	2,329 $45,000
Q3 2022 Nov 10, 2022	SELL	$19.98 - $29.44 $11,848 - $17,457	-593 Reduced 21.16%	2,210 $46,000
Q2 2022 Aug 15, 2022	SELL	$18.42 - $27.5 $52,975 - $79,090	-2,876 Reduced 50.64%	2,803 $55,000
Q1 2022 May 12, 2022	BUY	$15.5 - $23.93 $24,970 - $38,551	1,611 Added 39.6%	5,679 $125,000
Q4 2021 Feb 14, 2022	BUY	$13.05 - $19.35 $45,492 - $67,454	3,486 Added 598.97%	4,068 $65,000
Q3 2021 Nov 15, 2021	SELL	$13.95 - $20.18 $878 - $1,271	-63 Reduced 9.77%	582 $12,000
Q2 2021 Aug 16, 2021	BUY	$15.84 - $20.6 $126 - $164	8 Added 1.26%	645 $11,000
Q1 2021 May 17, 2021	SELL	$16.29 - $21.92 $80,146 - $107,846	-4,920 Reduced 88.54%	637 $13,000
Q4 2020 Feb 16, 2021	SELL	$15.75 - $25.45 $15,419 - $24,915	-979 Reduced 14.98%	5,557 $97,000
Q3 2020 Nov 16, 2020	BUY	$18.4 - $26.59 $98,918 - $142,947	5,376 Added 463.45%	6,536 $126,000
Q2 2020 Aug 13, 2020	BUY	$11.51 - $20.97 $13,351 - $24,325	1,160 New	1,160 $23,000
Q4 2019 Feb 07, 2020	SELL	$6.84 - $25.9 $6,060 - $22,947	-886 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$9.16 - $14.77 $8,115 - $13,086	886 New	886 $9,000

Others Institutions Holding MIRM

# of Institutions

195

Shares Held

54M

Call Options Held

177K

Put Options Held

167K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.85B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Mirum Pharmaceuticals, Inc. Transaction History